Based in Sweden, ArgusEye is a startup. Brouky records 1 investor associated with the company.
ArgusEye develops advanced biosensor technologies, including the patented Auga® platform, for real-time monitoring and analytics of biopharmaceutical manufacturing processes to improve process control and efficiency.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.